Metabolic syndrome-like components and prostate cancer risk: results from the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) study

OBJECTIVE: To evaluate the relationship between number of metabolic syndrome (MetS)-like components and prostate cancer diagnosis in a group of men where nearly all biopsies were taken independent of prostate-specific antigen (PSA) level, thus minimising any confounding from how the various MetS-lik...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:BJU Int
Main Authors: Sourbeer, Katharine N., Howard, Lauren E., Andriole, Gerald L., Moreira, Daniel M., Castro-Santamaria, Ramiro, Freedland, Stephen J., Vidal, Adriana C.
Formato: Artigo
Idioma:Inglês
Publicado: 2014
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4564864/
https://ncbi.nlm.nih.gov/pubmed/24931061
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bju.12843
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares